- Home
- CTOS vs CRGX Comparison
CTOS vs CRGX Comparison
Compare CTOS & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTOS
- CRGX
- Stock Information
- Founded
- CTOS 1988
- CRGX 2021
- Country
- CTOS United States
- CRGX United States
- Employees
- CTOS N/A
- CRGX N/A
- Industry
- CTOS Diversified Commercial Services
- CRGX
- Sector
- CTOS Consumer Discretionary
- CRGX
- Exchange
- CTOS Nasdaq
- CRGX Nasdaq
- Market Cap
- CTOS 881.1M
- CRGX 815.7M
- IPO Year
- CTOS N/A
- CRGX 2023
- Fundamental
- Price
- CTOS $3.39
- CRGX $21.70
- Analyst Decision
- CTOS Buy
- CRGX Strong Buy
- Analyst Count
- CTOS 5
- CRGX 7
- Target Price
- CTOS $7.10
- CRGX $30.33
- AVG Volume (30 Days)
- CTOS 523.2K
- CRGX 416.1K
- Earning Date
- CTOS 10-30-2024
- CRGX 11-21-2024
- Dividend Yield
- CTOS N/A
- CRGX N/A
- EPS Growth
- CTOS N/A
- CRGX N/A
- EPS
- CTOS N/A
- CRGX N/A
- Revenue
- CTOS $1,790,427,000.00
- CRGX N/A
- Revenue This Year
- CTOS $0.58
- CRGX N/A
- Revenue Next Year
- CTOS $2.24
- CRGX N/A
- P/E Ratio
- CTOS N/A
- CRGX N/A
- Revenue Growth
- CTOS 2.11
- CRGX N/A
- 52 Week Low
- CTOS $3.03
- CRGX $13.14
- 52 Week High
- CTOS $7.00
- CRGX $33.92
- Technical
- Relative Strength Index (RSI)
- CTOS 45.00
- CRGX 58.91
- Support Level
- CTOS $3.30
- CRGX $19.61
- Resistance Level
- CTOS $3.49
- CRGX $19.51
- Average True Range (ATR)
- CTOS 0.15
- CRGX 1.19
- MACD
- CTOS 0.03
- CRGX 0.36
- Stochastic Oscillator
- CTOS 60.00
- CRGX 73.67
About CTOS Custom Truck One Source Inc.
Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.